Condition: Hyperlactatemia · Metabolic Syndrome (MetS) · Lipolysis · Sponsor: Ricardo Mora
The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.
This description comes directly from the study's public registry record.
Ricardo MORA RODRIGUEZ, PhD · +34675424515 · ricardo.mora@uclm.es
Jesus Garcia-Pallares, PhD · +34665505278 · jgpallares@um.es
Always discuss trial participation with your own doctor first.
| Facultad de Ciencias del Deporte | San Javier, Murcia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07426172